Larson Financial Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.1K Buy
7,996
+6,726
+530% +$50.7K ﹤0.01% 1644
2026
Q2
$13.2K Sell
1,270
-91
-7% -$1.02K ﹤0.01% 2238
2026
Q1
$16.2K Buy
1,361
+401
+42% +$4.1K ﹤0.01% 1963
2025
Q4
$9.6K Buy
960
+934
+3,592% +$8.92K ﹤0.01% 2139
2025
Q3
$233 Sell
26
-3
-10% -$28 ﹤0.01% 3238
2025
Q2
$273 Buy
29
+21
+263% +$185 ﹤0.01% 2999
2025
Q1
$87 Hold
8
– – ﹤0.01% 2937
2024
Q4
$76 Hold
8
– – ﹤0.01% 2644
2024
Q3
$90 Hold
8
– – ﹤0.01% 2550
2024
Q2
$80 Buy
+8
New +$81 ﹤0.01% 2289

Other funds holding AHCO

Larson Financial Group's AHCO Position: Q3 2026 in Review

Larson Financial Group increased its AdaptHealth (AHCO) stake by 530% in Q3 2026, buying an estimated $50.7K and bringing the position to 7,996 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1644.

Larson Financial Group first reported a position in AHCO in Q2 2024 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Larson Financial Group held 7,996 shares of AdaptHealth worth $45.1K as of Q3 2026.
  • Larson Financial Group bought 6,726 AdaptHealth shares in Q3 2026, an estimated $50.7K.
  • AdaptHealth made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1644 holding.
  • Larson Financial Group first reported a position in AdaptHealth in Q2 2024 and has held it in 10 quarters since.
  • 248 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.